- Home
- LPG vs NVCR Comparison
LPG vs NVCR Comparison
Compare LPG & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPG
- NVCR
- Stock Information
- Founded
- LPG 2013
- NVCR 2000
- Country
- LPG United States
- NVCR Switzerland
- Employees
- LPG N/A
- NVCR N/A
- Industry
- LPG Marine Transportation
- NVCR Medical/Dental Instruments
- Sector
- LPG Consumer Discretionary
- NVCR Health Care
- Exchange
- LPG Nasdaq
- NVCR Nasdaq
- Market Cap
- LPG 1.4B
- NVCR 1.4B
- IPO Year
- LPG 2014
- NVCR 2015
- Fundamental
- Price
- LPG $26.89
- NVCR $13.79
- Analyst Decision
- LPG Strong Buy
- NVCR Buy
- Analyst Count
- LPG 1
- NVCR 7
- Target Price
- LPG $35.00
- NVCR $28.79
- AVG Volume (30 Days)
- LPG 448.3K
- NVCR 1.7M
- Earning Date
- LPG 10-31-2025
- NVCR 10-30-2025
- Dividend Yield
- LPG 11.90%
- NVCR N/A
- EPS Growth
- LPG N/A
- NVCR N/A
- EPS
- LPG 1.15
- NVCR N/A
- Revenue
- LPG $320,692,009.00
- NVCR $630,160,000.00
- Revenue This Year
- LPG $17.26
- NVCR $6.68
- Revenue Next Year
- LPG N/A
- NVCR $7.01
- P/E Ratio
- LPG $23.36
- NVCR N/A
- Revenue Growth
- LPG N/A
- NVCR 14.58
- 52 Week Low
- LPG $16.66
- NVCR $10.87
- 52 Week High
- LPG $33.67
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- LPG 33.02
- NVCR 53.88
- Support Level
- LPG $25.50
- NVCR $12.84
- Resistance Level
- LPG $27.24
- NVCR $14.60
- Average True Range (ATR)
- LPG 0.70
- NVCR 0.68
- MACD
- LPG -0.21
- NVCR -0.02
- Stochastic Oscillator
- LPG 30.54
- NVCR 56.48
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.